newsfilter
← Latest News
GlobeNewswire·

Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference

  • Aligos Therapeutics, Inc. (NASDAQ: ALGS) announced that management will present at the H.C. Wainwright Liver Disease Conference on October 21-22, 2025.
  • A webcast of the presentation will be accessible via the "Investors" section of the company website at www.aligos.com.
  • A replay of the webcast will be available for at least 30 days following the presentation.
  • Aligos is a clinical stage biotechnology company developing therapies for liver and viral diseases, including chronic hepatitis B, MASH, and coronaviruses.
  • The press release includes forward-looking statements subject to risks outlined in the company's Form 10-Q filed on August 6, 2025.
  • Contact information is provided for Jordyn Tarazi (Investor Relations) and Jake Robison (Media Contact at Inizio Evoke).